Graham Capital Management, L.P. Guardant Health, Inc. Transaction History

Graham Capital Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $211,469 - $332,203	-12,345 Reduced 29.29%	29,804 $614,000
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $171,086 - $233,876	7,928 Added 23.17%	42,149 $1.14 Million
Q3 2023 Nov 22, 2023	BUY	$25.8 - $39.97 $549,153 - $850,761	21,285 Added 164.54%	34,221 $1.01 Million
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $943,158 - $1.71 Million	-45,041 Reduced 77.69%	12,936 $463,000
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $253,380 - $373,216	11,055 Added 23.56%	57,977 $1.36 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $1.19 Million - $2.8 Million	46,922 New	46,922 $1.28 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $1.89 Million - $5.08 Million	-65,644 Reduced 83.77%	12,717 $513,000
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $3.11 Million - $6.47 Million	64,367 Added 459.96%	78,361 $5.19 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $1.24 Million - $1.69 Million	13,994 New	13,994 $1.4 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.